CONVERSION OF EPOXIDES TO VICINAL HALOESTERS
1037
43 (CH3CO, 100%). Anal. calcd. for C11H13IO3 (320.13): C, 41.27; H, 4.09; I, 39.64.
Found: C, 41.23; H, 4.06; I, 39.69.
1-Chloro-3-isopropyloxypropan-2-yl benzoate (3)[25] 1H NMR (CDCl3,
.
500 MHz): d 1.20–1.21 (d, 6H, J ¼ 6.07 Hz), 3.66–3.71 (m, 1H), 3.75–3.79 (m, 2H),
3.86–3.89 (dd, 1H, J ¼ 11.67, 5.24 Hz), 3.92–3.95 (dd, 1H, J ¼ 11.63, 4.59 Hz),
5.36–5.41 (m, 1H), 7.47–7.50 (m, 2H), 7.60–7.63 (m, 1H), 8.10–8.12 (m, 2H) ppm;
13C NMR (CDCl3, 125.77 MHz): d 22.44, 43.68, 66.52, 72.86, 72.94, 128.83,
130.22, 130.25, 133.65, 166.17 ppm.
1-Allyloxy-3-iodopropan-2-yl acetate (8). 1H NMR (CDCl3, 500 MHz): d
2.12 (s, 3H), 3.33–3.37 (dd, 1H, J ¼ 10.47, 5.55 Hz), 3.43–3.47 (dd, 1H, J ¼ 10.46,
5.68 Hz), 3.57–3.60 (dd, 1H, J ¼ 10.42, 5.01 Hz), 3.66–3.69 (dd, 1H, J ¼ 10.42,
4.98 Hz), 4.02–4.05 (m, 2H), 4.90–4.92 (m, 1H), 5.21–5.24 (dd, 1H, J ¼ 10.40,
1.42 Hz), 5.28–5.32 (dd, 1H, J ¼ 17.25, 1.6 Hz), 5.86–5.93 (m, 1H) ppm; 13C NMR
(CDCl3, 125.77 MHz): d 4.36, 21.44, 70.42, 71.79, 72.77, 117.96, 134.59, 170.47 ppm;
FT-IR (neat): 3030 (w), 3013 (w), 2924 (w), 2856 (w), 1747 (s), 1636 (m), 1232 (s),
668 (w), 599 (w), 517 (w) cmꢁ1; mass spectra m=e: 284 (M, 0.3%), 241 (M – CH3CO,
2.9%), 227 (M – C3H5O, 35.2%), 157 (M – I, 100%), 43 (CH3CO, 100%). Anal. calcd.
for C8H13IO3 (284.09): C, 33.82; H, 4.61; I, 44.67. Found: C, 33.89; H, 4.63; I, 44.64.
Trans-1-acetoxy-2-bromocyclohexane (2). Bp ¼ 110–111 ꢀC (12 mm.)
[lit.[33] 109–110 ꢀC (12 mm.)]; FT-IR (neat): 2930 (m), 2862 (m), 1743 (s), 1235 (s),
1038 (m), 696 (w), 602 (w) cmꢁ1
.
Trans-1-benzoyloxy-2-bromocyclohexane (4)[34] 1H NMR (CDCl3,
.
500 MHz): d 1.36–1.39 (m, 1H), 1.47–1.53 (m, 2H), 1.75–1.83 (m, 3H), 2.22–2.32
(m, 2H), 4.01–4.06 (m, 1H), 5.04–5.08 (m, 1H), 7.41–7.45 (m, 2H), 7.53–7.57 (m,
1H), 8.03–8.07 (m, 2H) ppm; 13C NMR (CDCl3, 125.77 MHz): d 23.62, 24.80,
31.00, 35.08, 60.99, 76.77, 128.79, 130.12, 130.70, 133.43, 166.12 ppm; FT-IR (neat):
3069 (w), 3021 (w), 2973 (m), 2930 (w), 2873 (w), 1723 (s), 1602 (w), 1585 (w), 1451
(w), 1270 (s), 1111 (s), 1026 (w), 711 (s), 686 (w) cmꢁ1
2-Chloro-1-phenylethyl acetate (6)[24] 1H NMR (CDCl3, 500 MHz): d 2.14
.
.
(s, 3H), 3.71–3.74 (dd, 1H, J ¼ 11.66, 4.5 Hz), 3.77–3.81 (dd, 1H, J ¼ 11.66, 8.05 Hz),
5.95–5.98 (dd, 1H, J ¼ 8.06, 4.5 Hz), 7.33–7.42 (m, 5H) ppm; 13C-NMR (CDCl3,
125.77 MHz): d 21.40, 46.93, 75.51, 127.09, 129.17, 129.25, 137.64, 170.30 ppm.
2-Chloro-2-phenylethyl acetate (7)[25] 1H NMR (CDCl3, 500 MHz): d 2.06
.
(s, 3H), 4.41–4.44 (dd, 1H, J ¼ 11.74, 5.93 Hz), 4.45–4.49 (dd, 1H, J ¼ 11.74, 7.81 Hz),
5.06–5.09 (dd, 1H, J ¼ 7.71, 5.96 Hz), 7.33–7.42 (m, 5H) ppm; 13C NMR (CDCl3,
125.77 MHz): d 21.15, 60.05, 68.30, 127.83, 129.23, 129.39, 138.06, 170.88 ppm.
1
1-Bromo-3-chloropropan-2-yl acetate (9)[25]. H NMR (CDCl3,
500 MHz): d 2.16 (s, 3H), 3.62–3.64 (m, 2H), 3.78–3.80 (m, 2H), 5.18–5.20 (m, 1H)
ppm; 13C-NMR (CDCl3, 125.77 MHz): d 21.21, 30.71, 43.74, 71.79, 170.24 ppm;
FT-IR (neat): 2962 (m), 2924 (m), 1748 (s), 1373 (m), 1228 (s), 1032 (m), 745 (w),
602 (w) cmꢁ1; mass spectra m=e: 181 (M þ 4 – 37Cl or M þ 2 – 35Cl, 1.5%), 179
(M þ 2 – 37Cl or M – 35Cl, 1.5%), 167 (M þ 4 – CH237Cl or M þ 2 – CH235Cl, 87%),
165 (M þ 2 – CH237Cl or M – CH235Cl, 82%), 158 (M þ 4 – CH3CO2H, 12%), 156